Literature DB >> 32951905

Mesoportal bypass, interposition graft, and mesocaval shunt: Surgical strategies to overcome superior mesenteric vein involvement in pancreatic cancer.

Benedict Kinny-Köster1, Floortje van Oosten2, Joseph R Habib1, Ammar A Javed1, John L Cameron1, Kelly J Lafaro1, Richard A Burkhart1, William R Burns1, Jin He1, Elliot K Fishman3, Christopher L Wolfgang4.   

Abstract

BACKGROUND: In pancreatic cancer, extensive tumor involvement of the mesenteric venous system poses formidable challenges to operative resection. Such involvement can result from cavernous collateral veins leading to increased intraoperative blood loss or long-segment vascular defects of not only just the superior mesenteric vein but also even jejunal/ileal branches. Strategies to facilitate margin-free resection and safe vascular reconstruction in pancreatic surgery are important, particularly because systemic control of the tumor is improving with multi-agent chemotherapy regimens.
METHODS: We describe a systematic, multidisciplinary assessment for patients with pancreatic cancer that involves the superior mesenteric vein, as well as the preoperative planning of those undergoing operative resection. In addition, detailed descriptions of operative approaches and technical strategies, which evolved with increasing experience at a high-volume center, are presented.
RESULTS: For the preoperative evaluation of tumor-free, vascular locations for potential reconstruction and collateralization, computed tomographic imaging with high-resolution of vascular structures (used with 3-dimensional or cinematic rendering) allows a precise calibration of radiographic data with intraoperative findings. From an operative perspective, we identified 5 potential strategies to consider for resection: collateral preservation, mesoportal bypass (preresection), mesoportal interposition graft (postresection), mesocaval shunt, and various combinations of these strategies. Many of these techniques use interposition grafts, making it essential to assess autologous veins (preferred conduit for reconstruction) or to prepare cryopreserved vascular allografts (an alternative conduit, which must be thawed and should be matched for size and blood type).
CONCLUSION: Herein we share operative strategies to overcome involvement of the superior mesenteric vein in pancreatic cancer. Improvements in preoperative planning and operative technique can address common barriers to resection with curative intent.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32951905     DOI: 10.1016/j.surg.2020.07.054

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.

Authors:  Georgios Gemenetzis; Alex B Blair; Minako Nagai; William R Burns; Christopher L Wolfgang; Jin He; Vincent P Groot; Ding Ding; Ammar A Javed; Richard A Burkhart; Elliot K Fishman; Ralph H Hruban; Matthew J Weiss; John L Cameron; Amol Narang; Daniel Laheru; Kelly Lafaro; Joseph M Herman; Lei Zheng
Journal:  Ann Surg Oncol       Date:  2021-08-27       Impact factor: 5.344

2.  Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome.

Authors:  Sami Shoucair; Joseph R Habib; Ning Pu; Benedict Kinny-Köster; A Floortje van Ooston; Ammar A Javed; Kelly J Lafaro; Jin He; Christopher L Wolfgang; Jun Yu
Journal:  Ann Surg Oncol       Date:  2021-11-18       Impact factor: 5.344

3.  The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience.

Authors:  Ammar A Javed; Joseph R Habib; Benedict Kinny-Köster; Mary Hodgin; Lindsay Parish; Dea Cunningham; Amy Hacker-Prietz; Richard A Burkhart; William R Burns; Christopher R Shubert; John L Cameron; Atif Zaheer; Linda C H Chu; Satomi Kawamoto; Elizabeth D Thompson; Eun J Shin; Amol Narang; Lei Zheng; Daniel A Laheru; Ralph H Hruban; Jin He; Christopher L Wolfgang; Elliot K Fishman; Kelly Lafaro
Journal:  Curr Probl Diagn Radiol       Date:  2022-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.